Navigation Links
Althea Technologies Acquires Altus Pharmaceuticals'(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
Date:5/2/2010

SAN DIEGO, May 2 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of services for biopharmaceutical development and manufacturing announced today that it has acquired the assets and IP portfolio of Altus Pharmaceuticals. The IP portfolio includes, among other things, Altus' Cross Linked Enzyme Crystal (CLEC®) and controlled release injectable technologies.  Applications of this protein crystal technology range from therapeutics to protein purification and catalysis. The controlled release injectable technology involves protein crystallization and complexation using customized manufacturing equipment installed at Althea.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)

Additionally, the assets encompass a portfolio of product candidates based on these technologies which includes a seven day controlled release growth hormone injectable which has completed a phase 2 clinical trial. Althea was the manufacturer of the clinical supplies for this product candidate. Althea plans to enter into licensing discussions for these product candidates.

"We are delighted to acquire this portfolio of technologies which complements our core expertise in protein formulation and will bring added value to our customers' projects," commented Dr. Shabbir Anik, CEO of Althea Technologies. "We expect multiple applications for a broad range of proteins, peptides and vaccines addressing the need for controlled release, high concentration formulations, and stability," he added.

Althea will be exhibiting at the BIO International Convention: Booth #5940.

About Althea Technologies, Inc.

Althea Technologies is a fully integrated, contract development and manufacturing organization that provides services for plasmids, protein biologics and sterile products. Located in San Diego, CA, Althea offers cell banking, process development, cGMP protein & plasmid production, analytical development, formulation development, aseptic filling in vials & prefilled syringes, and lyophilization services for clinical development and commercialization.  For more information, visit www.altheatech.com.


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
2. China Medical Technologies to Announce Results for the Fourth Fiscal Quarter and the Fiscal Year Ended March 31, 2010 on June 4, 2010
3. China Medical Technologies to Participate in Investor Conferences in May and June 2010
4. CareFusion, Cerner to Integrate Technologies for Improved Hospital Safety, Efficiency
5. Lakeside Behavioral Healthcare Named Winner of First Annual Netsmart Technologies Customer Innovation Award
6. MultiCell Technologies Is Granted European Patent for the Treatment of Cancer
7. MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Abbott Completes Acquisition of STARLIMS Technologies
10. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
11. Rauland-Borg and Visonic Technologies Collaboration Brings Enhanced RTLS Functionality to the Responder 5(R) Nurse Call System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
(Date:5/24/2016)... Cirujanos holandeses han puesto en ... médicos a compartir sus mejores prácticas por el mundo ... médicos de Europa, África, Asia ... aplicación, que combina la transmisión en vivo con mensajería ... Educación   "Imagine un médico de Medicines ...
(Date:5/24/2016)...   , Study met ... and superiority in , Excellent plus ... of the ascending colon   , ... B.V. today announced new positive data from the phase III MORA ... standard 2 litre PEG with ascorbate. The study met both primary ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare ... suppliers for its inaugural Member Conference at the Paris Hotel in Las Vegas, ... operational health of America’s healthcare providers. , The conference was highlighted by the ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... one that has a significant negative impact on long-term patient survival, reports a ... The results, published online this week in the Journal of Thoracic and Cardiovascular ...
(Date:5/26/2016)... ... May 26, 2016 , ... An April Gallup survey found rising health care ... of Sun Health Senior Living (SHSL) may not share those same worries ... prescription copays for the year, while holding the line on increasing their contributions, including ...
(Date:5/26/2016)... ... , ... The Lung Institute has partnered with the Gulfcoast North ... 6 at their clinic in downtown Tampa. The class is complimentary for the public. ... created a free downloadable 4 Week Smoking Cessation Guide for those who ...
(Date:5/26/2016)... ... May 26, 2016 , ... Eugene Batelli, D.P.M., ... with his wonderful accolades and stellar patient reviews, Dr. Batelli continues to be ... Dr. Eugene Batelli is a highly trained Podiatric Surgeon who specializes in treating ...
Breaking Medicine News(10 mins):